The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
September 11th 2025
Researchers uncover a brain circuit linking stress to increased blood sugar, revealing insights into stress's role in type 2 diabetes (T2D) development.
Subcutaneous Herceptin Combo Therapy for Certain Breast Cancer Patients Granted FDA Approval
February 28th 2019Trastuzumab and hyaluronidase-oysk (Herceptin Hylecta, Genentech) is indicated for subcutaneous administration in certain patients with HER2-positive early and metastatic breast cancer.
Read More
FDA Approves TAS-102 for Treating Adults With Gastric/GEJ Cancer
February 25th 2019The drug is indicated for those patients who were previously treated with at least 2 prior lines of chemotherapy that included a fluoropyrimidine, a platinum, either a taxane or irinotecan, and if appropriate, HER2/neu-targeted therapy.
Read More
Detection of Impurity Prompts Company to Recall 1 Lot of Combination Tablets
February 23rd 2019Macleods Pharmaceuticals Limited has voluntarily recalled 1 lot of Losartan Potassium/Hydrochlorothiazide combination tablets 100mg/25mg to the consumer level, due to the detection of trace amounts of an unexpected impurity found in the product that is above the acceptable daily intake levels released by the FDA.
Read More